Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amylx Pharmaceuticals Inc (AMLX) vs Standard Lithium Ltd (SLI) Price & Performance

Amylx Pharmaceuticals IncTrade
Standard Lithium LtdTrade

Price performance (Past 24H)

Key statistics

Amylx Pharmaceuticals Inc vs Standard Lithium Ltd — how do they compare? Amylx Pharmaceuticals Inc trades at $23.65 (market cap $2.64B), while Standard Lithium Ltd trades at $2.41 (market cap $604.50M). The key difference: Amylx Pharmaceuticals Inc is far larger — about 4.4× Standard Lithium Ltd's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, Standard Lithium Ltd nearer its low. Which is the better fit depends on your goals.

AMLXSLI
Market Cap
$2.64B$604.50M
Sector
HealthBasic Materials
52-Week High
$24.19$5.65
52-Week Low
$7.82$1.93
Enterprise Value
$2.39B$467.42M

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amylx Pharmaceuticals Inc

Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.

Read more on AMLX

About Standard Lithium Ltd

Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.

Read more on SLI